Latest / Applied Clinical Trials
ACT Brief: AI Decision-Making, Sponsor Oversight Trends, and HHS Label Changes
In today’s ACT Brief, we look at how artificial intelligence is reshaping drug development decisions across pharma, discuss evolving sponsor oversight in site selection and protocol design, and review the FDA’s decision to update menopausal hormone therapy labels for clarity and safety.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.